Sign in
4

Changes in Ownership

abrdn Life Sciences Investors Filed Acc 0001510281-25-000113

10% owner sold 200 shares at $13.62 ($2,724)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Saba Capital Management, L.P. 10% owner 2025-02-26 Sale −200 $13.62 $2,724 3,275,881 I
Open-market sales · 200 sh · avg $13.62 · $2,724
Loading xslF345X05/primary_doc.xml…